Japan Health Authority approves Biocon Biologics’ Ustekinumab BS, Biosimilar to J&J's Stelara
The biosimilar Ustekinumab has been developed and manufactured by the company
The biosimilar Ustekinumab has been developed and manufactured by the company
With 6 operation hubs and 18 offices across North America, Europe, and Asia, Indegene’s client base includes the world’s top 20 biopharma companies
This agreement reinforces Lubrizol’s commitment to Make-In-India and broadens a previously committed US$ 350 million investment to support local manufacturing
He holds a Master’s in Management from the National University of Singapore
The inspection concluded with the issuance of a form 483 with five observations
This initiative aims to raise awareness about the importance of monitoring blood sugar levels before indulging in sweets
MedTech Mitra initiative aims to empower MedTech innovators and advance healthcare solutions
Ami informs that PMDA Japan has issued Inspection Result Report declaring the Sachin facility as a Good Manufacturing Practices (GMP) compliant.
Subscribe To Our Newsletter & Stay Updated